Maravai Lifesciences Holdings (MRVI) Net Cash Flow Growth (5y) (2025 - 2026)
Maravai Lifesciences Holdings (MRVI) Net Cash Flow Growth (5y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,784.63 Bn | 1,784.57 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.29 Bn | 468.50 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.58 Bn | 116.33 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.82 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.20 Bn | 62.20 Bn | - |
| 7 | Argenx Se | 54.55 Bn | 49.37 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.25 Bn | 36.25 Bn | - |
| 10 | Maravai Lifesciences Holdings | 1.01 Bn | 845.88 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.14% |
| Dec 31, 2025 | -17.50% |
| Sep 30, 2025 | -21.54% |
| Jun 30, 2025 | -31.64% |
| Mar 31, 2025 | -22.14% |